Current Diabetes Reports

Papers
(The median citation count of Current Diabetes Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Diabetes Complications in Racial and Ethnic Minority Populations in the USA79
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk73
Sleep Regularity and Cardiometabolic Heath: Is Variability in Sleep Patterns a Risk Factor for Excess Adiposity and Glycemic Dysregulation?59
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease54
Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent52
Eating Disorders and Diabetes50
Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine44
Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema41
Artificial Intelligence in Current Diabetes Management and Prediction41
Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus39
Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease38
Tissue-Specific Fructose Metabolism in Obesity and Diabetes36
Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes34
Genetic Studies of Gestational Diabetes and Glucose Metabolism in Pregnancy32
Periodic and Intermittent Fasting in Diabetes and Cardiovascular Disease31
Dyslipidemia in Pediatric Type 2 Diabetes Mellitus30
Adipose Tissue Inflammation and Cardiovascular Disease: An Update28
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications27
Genetics of Type 2 Diabetes: Implications from Large-Scale Studies26
The Financial Impact of an Inpatient Diabetes Management Service25
Pancreas-on-a-Chip Technology for Transplantation Applications24
Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy24
Updates on Gene Therapy for Diabetic Retinopathy23
Association Between Diabetes, Diabetic Retinopathy, and Glaucoma23
Social Determinants of Poor Management of Type 2 Diabetes Among the Insured23
PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine22
Type 2 Diabetes in Youth: the Role of Early Life Exposures22
The Prevalence of Diabetic Microvascular Complications in China and the USA22
The Use of Diabetes Technology to Address Inequity in Health Outcomes: Limitations and Opportunities21
A Systematic Review of Cost-Effectiveness of Sodium-Glucose Cotransporter Inhibitors for Type 2 Diabetes21
Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review21
Inter-organelle Communication in the Pathogenesis of Mitochondrial Dysfunction and Insulin Resistance20
Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad20
Managing Diabetes in Hard to Reach Populations: A Review of Telehealth Interventions20
CNS Regulation of Glucose Homeostasis: Role of the Leptin-Melanocortin System20
Management of Complications and Vision Loss from Proliferative Diabetic Retinopathy20
Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar20
Diabetes in People with HIV19
Euglycemic Ketoacidosis19
The Impact of Meal Timing on Risk of Weight Gain and Development of Obesity: a Review of the Current Evidence and Opportunities for Dietary Intervention19
How Do the Challenges of Emerging Adulthood Inform our Understanding of Diabetes Distress? An Integrative Review19
The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction18
Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony18
Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease17
The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment17
Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear17
Bariatric Surgery for Monogenic Non-syndromic and Syndromic Obesity Disorders17
Diabetes Risk and Control in Multi-ethnic US Immigrant Populations17
Brain Health in Children with Type 1 Diabetes: Risk and Protective Factors17
Depression in Youth-Onset Type 2 Diabetes17
Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review16
Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism16
Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes16
Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes?16
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment16
Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome16
Intermittent Fasting as Part of the Management for T2DM: from Animal Models to Human Clinical Studies16
Use of Machine Learning Approaches in Clinical Epidemiological Research of Diabetes15
Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes15
Sleep Apnea and Cardiovascular Disease15
Using Person-Reported Outcomes (PROs) to Motivate Young People with Diabetes15
Cardiometabolic Morbidity and Mortality with Smoking Cessation, Review of Recommendations for People with Diabetes and Obesity14
Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms14
COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study14
Predicting and Preventing Acute Care Re-Utilization by Patients with Diabetes14
Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management14
miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes13
Type 1 Diabetes, Sleep, and Hypoglycemia13
Sleep Extension: A Potential Target for Obesity Treatment13
Young Children with Type 1 Diabetes: Recent Advances in Behavioral Research13
Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes13
Physiological and Lifestyle Traits of Metabolic Dysfunction in the Absence of Obesity12
Novel Treatments for Diabetic Macular Edema and Proliferative Diabetic Retinopathy12
Lipodystrophy for the Diabetologist—What to Look For12
New Insights into the Genetics of Latent Autoimmune Diabetes in Adults12
Body Composition Methods in Adults with Type 2 Diabetes or at Risk for T2D: a Clinical Review12
Review of Intravenous and Subcutaneous Electronic Glucose Management Systems for Inpatient Glycemic Control12
Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts12
A Model of Adolescent Sleep Health and Risk for Type 2 Diabetes12
Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy11
Does Weight Loss Improve Clinical Outcomes in Overweight and Obese Patients with Heart Failure?11
Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps11
Friend or Foe: a Narrative Review of the Impact of Diabetes Technology on Sleep11
Lipidomic Abnormalities During the Pathogenesis of Type 1 Diabetes: a Quantitative Review10
The Relationship Between Executive Functioning, Type 1 Diabetes Self-Management Behaviors, and Glycemic Control in Adolescents and Young Adults10
Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease10
Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices10
Moving Diabetes Upstream: the Social Determinants of Diabetes Management and Control Among Immigrants in the US10
Diabetes Management During Breastfeeding in Women with Type 1 Diabetes10
CGM in the Hospital: Is It Ready for Prime Time?9
The Role of Programmed Death-1 in Type 1 Diabetes9
Patient-Centered Diabetes Care of Cancer Patients9
Machine Learning Models for Inpatient Glucose Prediction9
Novel Challenges in Aging with Type 1 Diabetes9
Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes9
The Value of Measuring Diabetes Burnout9
Early Onset of Autoimmune Diabetes in Children with Down Syndrome—Two Separate Aetiologies or an Immune System Pre-Programmed for Autoimmunity?8
Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes Endotypes8
Endocrine Mechanisms Connecting Exercise to Brown Adipose Tissue Metabolism: a Human Perspective8
Toward a New Staging System for Diabetic Retinopathy Using Wide Field Swept-Source Optical Coherence Tomography Angiography8
Role of the Autonomic Nervous System in the Hemodynamic Response to Hyperinsulinemia—Implications for Obesity and Insulin Resistance8
Economic Simulation Modeling in Type 2 Diabetes8
The Diabetes-Cardiovascular Connection in Women: Understanding the Known Risks, Outcomes, and Implications for Care8
The Role of Ultra-Widefield Fundus Imaging and Fluorescein Angiography in Diagnosis and Treatment of Diabetic Retinopathy8
Managing Patients Undergoing Orthopedic Surgery to Improve Glycemic Outcomes8
Cognitive Behavioral Therapy and Mindfulness-Based Cognitive Therapy in Children and Adolescents with Type 2 Diabetes8
Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes7
Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes7
Integrated Behavioral Interventions for Adults with Comorbid Obesity and Depression: a Systematic Review7
Mobile Health Technology in the Primary Prevention of Type 2 Diabetes: a Systematic Review7
Thyroid Hormone Signalling Alteration in Diabetic Nephropathy and Cardiomyopathy: a “Switch” to the Foetal Gene Programme7
A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes7
Role of Glucose Metabolism and Mitochondrial Function in Diabetic Kidney Disease7
Purine Metabolite Signatures and Type 2 Diabetes: Innocent Bystanders or Actionable Items?7
The Physiological Importance of Bile Acid Structure and Composition on Glucose Homeostasis7
The β-Cell Genomic Landscape in T1D: Implications for Disease Pathogenesis7
Implementation of Technology-Delivered Diabetes Self-care Interventions in Clinical Care: a Narrative Review6
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists6
Novel Immunomodulatory Approaches for Porcine Islet Xenotransplantation6
Implementation of Psychosocial Screening into Diabetes Clinics: Experience from the Type 1 Diabetes Exchange Quality Improvement Network6
The Clash of Two Epidemics: the Relationship Between Opioids and Glucose Metabolism6
Molecular Aspects in the Potential of Vitamins and Supplements for Treating Diabetic Neuropathy6
0.024002075195312